Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Uchida

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
Anticancer Research|April 28, 2026
Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP GradeKosuke Hamada, Takeshi Yamasaki, Chisato Ohe, et al.
International Immunology|December 23, 2003
Mouse CD20 expression and functionJunji Uchida, Youngkyun Lee, Minoru Hasegawa, et al.
Japanese Journal of Pharmacology|December 26, 2002
Role of renin-angiotensin system and nuclear factor-kappaB in the obstructed kidney of rats with unilateral ureteral obstructionTatsuya Nakatani, Satoshi Tamada, Toshihiro Asai, et al.
Plos One|August 1, 2019
Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in JapanRyuya Edahiro, Masaki Kanazu, Hiroyuki Kurebe, et al.
Plos One|January 1, 2019
ABO-incompatible kidney transplantation as a renal replacement therapy-A single low-volume center experience in JapanAkihiro Kosoku, Junji Uchida, Shunji Nishide, et al.
In Vivo (Athens, Greece)|February 27, 2026
Onset and Outcomes of Immune-related Adverse Events in Genitourinary Cancer Treated With Immune Checkpoint InhibitorsMinoru Kato, Shoma Yamamoto, Taisuke Matsue, et al.
BMC Nephrology|June 8, 2019
Successful pregnancy after in vitro fertilization in an ABO-incompatible kidney transplant recipient receiving rituximab: a case reportAkihiro Kosoku, Junji Uchida, Keiko Maeda, et al.
The American Journal of Pathology|August 29, 2006
B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosisMinoru Hasegawa, Yasuhito Hamaguchi, Koichi Yanaba, et al.
BMC Cancer|February 5, 2020
Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumabMitsunori Morita, Motohiro Tamiya, Daichi Fujimoto, et al.
Lung Cancer (Amsterdam, Netherlands)|July 21, 2022
Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitisTakeya Sugimoto, Daichi Fujimoto, Yuki Sato, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Anticancer Research|April 28, 2026
Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP GradeKosuke Hamada, Takeshi Yamasaki, Chisato Ohe, et al.
International Immunology|December 23, 2003
Mouse CD20 expression and functionJunji Uchida, Youngkyun Lee, Minoru Hasegawa, et al.
Japanese Journal of Pharmacology|December 26, 2002
Role of renin-angiotensin system and nuclear factor-kappaB in the obstructed kidney of rats with unilateral ureteral obstructionTatsuya Nakatani, Satoshi Tamada, Toshihiro Asai, et al.
Plos One|August 1, 2019
Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in JapanRyuya Edahiro, Masaki Kanazu, Hiroyuki Kurebe, et al.
Plos One|January 1, 2019
ABO-incompatible kidney transplantation as a renal replacement therapy-A single low-volume center experience in JapanAkihiro Kosoku, Junji Uchida, Shunji Nishide, et al.
In Vivo (Athens, Greece)|February 27, 2026
Onset and Outcomes of Immune-related Adverse Events in Genitourinary Cancer Treated With Immune Checkpoint InhibitorsMinoru Kato, Shoma Yamamoto, Taisuke Matsue, et al.
BMC Nephrology|June 8, 2019
Successful pregnancy after in vitro fertilization in an ABO-incompatible kidney transplant recipient receiving rituximab: a case reportAkihiro Kosoku, Junji Uchida, Keiko Maeda, et al.
The American Journal of Pathology|August 29, 2006
B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosisMinoru Hasegawa, Yasuhito Hamaguchi, Koichi Yanaba, et al.
BMC Cancer|February 5, 2020
Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumabMitsunori Morita, Motohiro Tamiya, Daichi Fujimoto, et al.
Lung Cancer (Amsterdam, Netherlands)|July 21, 2022
Prospective multicenter cohort study of durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitisTakeya Sugimoto, Daichi Fujimoto, Yuki Sato, et al.
Pageof 23